Table 1 Demographic and clinical data of the studied groups
Patients | Control | p value | ||
|---|---|---|---|---|
Age (year) | 63 ± 8 | 62 ± 4 | 0.45 | |
Gender | ||||
Male | 25 (83.3%) | 25 (83.3%) | 0.73 | |
Female | 5 (16.7%) | 5 (16.7%) | ||
Duration (year) | 3 ± 1 | – | ||
Age at onset of the disease | 55 ± 7 | – | ||
Total UPDRS score | Range | 23–77 | – | |
Mean | 47 | |||
Median | 45 | |||
HY scale | Range | 1–3 | – | |
Mean | 2.4 ± 0.8 | |||
Median | 2 | |||
Treatment | ||||
Dopaminergic drugs | (22)73.3% | – | ||
Untreated | (5)16.7% | |||
Non-compliant | (3)10% | |||